Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Early HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by web@researchtop... on Wed, 11/23/2011 - 12:29
Consensus or Controversy, Issue 3: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Early HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by web@researchtop... on Wed, 11/23/2011 - 12:07
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Metastatic HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by mphilemon@resea... on Mon, 11/21/2011 - 11:33
 |
|||||
 |
|||||
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Metastatic HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by web@researchtop... on Sat, 11/19/2011 - 14:41
Email from the Editor
Click here to go directly to the web- and video-based education resources related to this week’s topic
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
Submitted by web@researchtop... on Thu, 11/17/2011 - 10:39
|
|||||
|
|||||
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
Submitted by web@researchtop... on Wed, 11/16/2011 - 16:49
Email from the Editor
Click here to go directly to the web- and video-based education resources related to this week’s topic
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Metastatic HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
Submitted by web@researchtop... on Tue, 11/15/2011 - 19:41
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
Submitted by web@researchtop... on Fri, 11/11/2011 - 13:29
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer
Submitted by web@researchtop... on Fri, 11/11/2011 - 13:01
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Hepatic-Only Metastatic Colon Cancer
Submitted by web@researchtop... on Sat, 11/05/2011 - 16:36
Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Prostate Cancer
Submitted by web@researchtop... on Tue, 11/01/2011 - 16:40
Monday Night with Research To Practice: Seminar VIII — Advanced Prostate Cancer
Submitted by mphilemon@resea... on Tue, 10/25/2011 - 15:15
Monday Night with Research To Practice: Seminar VII — Diffuse Large B-Cell Lymphoma (DLBCL)/T-Cell Lymphomas (TCL)/Mantle-Cell Lymphoma (MCL)
Submitted by mphilemon@resea... on Tue, 10/25/2011 - 15:13
Monday Night with Research To Practice: Seminar VI — HER2-Positive Gastric Cancer
Submitted by mphilemon@resea... on Tue, 10/25/2011 - 15:11
Monday Night with Research To Practice: Seminar V — Central Nervous System (CNS) Cancers
Submitted by mphilemon@resea... on Tue, 10/25/2011 - 15:09